Filter by
Filter by
Comprehensive radiotherapy for pediatric Ewing Sarcoma: Outcomes of a prospective proton study.
This study conducted by the MD Anderson group reported clinical results of 42 children with Ewing sarcoma treated with protons to a median total dose of 54...
Proton FLASH radiotherapy ameliorates radiation-induced salivary gland dysfunction and oral mucositis and increases survival in a mouse model of head and neck cancer.
Published by the Upenn group, this study reported reduced xerostomia with FLASH proton compared to standard proton therapy in mice. The head and neck area of...
FLASH Radiotherapy: What Can FLASH's Ultra High Dose Rate Offer to the Treatment of Patients With Sarcoma?
A review article by the Upenn group summarized the preclinical and clinical evidence for the FLASH effect and discussed the potential clinical significance for...
FLASH radiotherapy for the treatment of symptomatic bone metastases in the thorax (FAST-02): protocol for a prospective study of a novel radiotherapy approach.
This is a trial protocol of FAST-02. This trial includes 10 patients with 1-3 painful bone metastases in the thorax, excluding bone metastases in the spine...
A multicenter high-quality data registry for advanced proton therapy approaches: the POWER registry.
This article describes the POWER registry set up by the European Institute of Oncology (IEO), Milan, Italy. All patients with any type of oncologic disease...
Proton Beam Therapy for Children With Neuroblastoma: Experiences From the Prospective KiProReg Registry.
44 patients with high-risk (n = 39) or intermediate-risk (n = 5) neuroblastoma were treated with protons. With a median follow-up of 27.6 months, eight patients...